Short Interest in AB Corporate Bond ETF (NASDAQ:EYEG) Decreases By 54.5%

AB Corporate Bond ETF (NASDAQ:EYEG) was the target of a large decline in short interest in April. As of April 30th, there was short interest totaling 250 shares, a decline of 54.5% from the April 15th total of 549 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 99 shares, the short-interest ratio is presently 2.5 days.

Hedge Funds Weigh In On AB Corporate Bond ETF

Several hedge funds and other institutional investors have recently modified their holdings of EYEG. Jane Street Group LLC acquired a new position in shares of AB Corporate Bond ETF in the 2nd quarter valued at about $232,000. Wealth Enhancement Advisory Services LLC lifted its stake in shares of AB Corporate Bond ETF by 6.2% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 119,017 shares of the specialty pharmaceutical company’s stock valued at $4,301,000 after purchasing an additional 6,988 shares in the last quarter. Finally, Kestra Advisory Services LLC purchased a new stake in shares of AB Corporate Bond ETF during the 4th quarter valued at about $34,000. 64.16% of the stock is owned by institutional investors and hedge funds.

AB Corporate Bond ETF Trading Down 0.5%

Shares of NASDAQ EYEG traded down $0.18 during midday trading on Friday, hitting $35.01. The stock had a trading volume of 13 shares, compared to its average volume of 193. The company has a market capitalization of $28.01 million, a price-to-earnings ratio of -20.84 and a beta of 0.18. AB Corporate Bond ETF has a 1-year low of $34.59 and a 1-year high of $36.63. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.01. The company has a fifty day moving average price of $35.30 and a 200 day moving average price of $35.71.

AB Corporate Bond ETF Announces Dividend

The company also recently disclosed a monthly dividend, which was paid on Wednesday, May 6th. Stockholders of record on Friday, May 1st were paid a $0.1404 dividend. This represents a c) annualized dividend and a dividend yield of 4.8%. The ex-dividend date of this dividend was Friday, May 1st. AB Corporate Bond ETF’s payout ratio is currently -103.57%.

About AB Corporate Bond ETF

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.